GlassScriptPhysician profile
Rudolph Leibel
NPI 1891972402
$67,406.50
in general payments reported to CMS, 2019-2025
10 companies · $8,061 in 2025
The $8,061 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $7,669 · 2021: $980 · 2022: $8,668 · 2023: $12K · 2024: $13K · 2025: $8,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Travel and Lodging: $691 · Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,007.50 |
| Travel and Lodging | $690.85 |
| Food and Beverage | $287.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21,525.00 | 2021-2023 | |
| Eli Lilly and Company | $12,500.00 | 2024 | |
| Merck Sharp & Dohme LLC | $11,905.00 | 2019 | |
| Abbvie INC. | $6,666.29 | 2025 | |
| Janssen Research & Development, LLC | $5,198.36 | 2019 | |
| Boehringer Ingelheim International Gmbh | $4,869.35 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,800.00 | 2020 | |
| Novo Nordisk US Research & Development, INC. | $1,395.00 | 2025 | |
| Regeneron Pharmaceuticals, INC. | $547.50 | 2022 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rudolph Leibel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.